Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma

BACKGROUND: Pancreatic cancer has a 5-year survival rate of only 5–7%. Difficulties in detecting pancreatic cancer at early stages results in the high mortality and substantiates the need for additional diagnostic tools. Surgery is the only curative treatment and unfortunately only possible in local...

Descripción completa

Detalles Bibliográficos
Autores principales: Henriksen, Stine Dam, Madsen, Poul Henning, Larsen, Anders Christian, Johansen, Martin Berg, Drewes, Asbjørn Mohr, Pedersen, Inge Søkilde, Krarup, Henrik, Thorlacius-Ussing, Ole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112622/
https://www.ncbi.nlm.nih.gov/pubmed/27891190
http://dx.doi.org/10.1186/s13148-016-0286-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112622/
https://www.ncbi.nlm.nih.gov/pubmed/27891190
http://dx.doi.org/10.1186/s13148-016-0286-2

Ejemplares similares